Human insulin B24 (Phe----Ser). Secretion and metabolic clearance of the abnormal insulin in man and in a dog model.

We have already demonstrated that a hyperinsulinemic, diabetic subject secreted an abnormal insulin in which serine replaced phenylalanine B24 (Shoelson S., M. Fickova, M. Haneda, A. Nahum, G. Musso, E. T. Kaiser, A. H. Rubenstein, and H. Tager. 1983. Proc. Natl. Acad. Sci. USA. 80:7390-7394). High performance liquid chromatography analysis now shows that the circulating insulin in several other family members also consists of a mixture of the abnormal human insulin B24 (Phe----Ser) and normal human insulin in a ratio of approximately 9.5:1 during fasting. Although all affected subjects show fasting hyperinsulinemia, only the propositus and her father are overtly diabetic. Analysis of the serum insulin from two nondiabetic siblings revealed that normal insulin increased from approximately 2 to 15% of total serum insulin after the ingestion of glucose and that the proportion of the normal hormone plateaued or fell while the level of total insulin continued to rise. Animal studies involving the graded intraportal infusion of equimolar amounts of semisynthetic human [SerB24]-insulin and normal human insulin in pancreatectomized dogs (to simulate the secretion of insulin due to oral glucose in man) also showed both a rise in the fraction of normal insulin that reached the periphery and the attainment of a brief steady state in this fraction while total insulin levels continued to rise. Separate experiments documented a decreased hepatic extraction, a decreased metabolic clearance rate, and an increased plasma half-life of human [SerB24]-insulin within the same parameters as those determined for normal human insulin. These results form a basis for considering (a) the differential clearance of low activity abnormal insulins and normal insulin from the circulation in vivo, and (b) the causes of hyperinsulinemia in both diabetic and nondiabetic individuals who secrete abnormal human insulins.

[1]  M Fickova,et al.  Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[2]  D. Steiner,et al.  Studies on mutant human insulin genes: identification and sequence analysis of a gene encoding [SerB24]insulin. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[3]  T. Sanke,et al.  Three mutant insulins in man , 1983, Nature.

[4]  K. Polonsky,et al.  Differences in the hepatic and renal extraction of insulin and glucagon in the dog: evidence for saturability of insulin metabolism. , 1983, Acta endocrinologica.

[5]  H. Maegawa,et al.  Characterization of [LeuB-24]- and [LeuB-25]-insulin analogues. Receptor binding and biological activity. , 1982, The Biochemical journal.

[6]  E. Kaiser,et al.  [LeuB24]insulin and [AlaB24]insulin: altered structures and cellular processing of B24-substituted insulin analogs. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[7]  K. Polonsky,et al.  Glucose ingestion in dogs alters the hepatic extraction of insulin. In vivo evidence for a relationship between biologic action and extraction of insulin. , 1982, The Journal of clinical investigation.

[8]  [C-peptide and insulin in diabetics]. , 1982, Zhonghua yi xue za zhi.

[9]  K. Polonsky,et al.  Hepatic and renal metabolism of somatostatin-like immunoreactivity. Simultaneous assessment in the dog. , 1981, The Journal of clinical investigation.

[10]  H. Kehlet,et al.  Decreased insulin removal contributes to hyperinsulinemia in obesity. , 1981, The Journal of clinical endocrinology and metabolism.

[11]  D. Robbins,et al.  A human proinsulin variant at arginine 65 , 1981, Nature.

[12]  P. De Meyts,et al.  Impaired negative cooperativity of the semisynthetic analogues human [LeuB24]- and [LeuB25]-insulins. , 1981, Biochemical and biophysical research communications.

[13]  D. Steiner,et al.  Loss of a restriction endonuclease cleavage site in the gene of a structurally abnormal human insulin. , 1981, Biochemical and biophysical research communications.

[14]  J. Olefsky,et al.  Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Olefsky,et al.  Diabetes due to secretion of an abnormal insulin. , 1980, The New England journal of medicine.

[16]  J. Olefsky,et al.  A structurally abnormal insulin causing human diabetes , 1979, Nature.

[17]  P. Savage,et al.  C-Peptide and insulin secretion in Pima Indians and Caucasians: constant fractional hepatic extraction over a wide range of insulin concentrations and in obesity. , 1979, The Journal of clinical endocrinology and metabolism.

[18]  A. Rubenstein,et al.  31 – Insulin, Proinsulin, and C-Peptide , 1978 .

[19]  D L Horwitz,et al.  Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics , 1977, Diabetes.

[20]  D. Steiner,et al.  Retention and degradation of 125I-insulin by perfused livers from diabetic rats. , 1976, The Journal of clinical investigation.